February 19 - 24, 2017    San Francisco CA , USA
The recent successes of targeted therapies highlight both the opportunities and the challenges of personalizing cancer care. The combination of diagnostic tools with targeted agents can provide dramatic patient benefits, but improving the durability of clinical responses requires juxtaposition of clinical and pre-clinical studies to address the underlying disease biology. The opportunity provided by this paradigm is exemplified by our ongoing studies with RG7204, an inhibitor of V600E-BRAF.

Venue

Location: Moscone Convention Center
The Moscone Center is the largest convention and exhibition complex in San Francisco, California. It comprises three main halls: Two underground halls underneath Yerba Buena Gardens, known as..
Contact 747 Howard Street, 5th Flr. San Francisco , USA
415.974.4000, 415.974.4073

Organizer

Cambridge Healthtech Institute
250 First Avenue Suite 300 Needham, MA 02494
888-999-6288, 781-972-5400

Related events

Pathway-Targeted Therapies in Cancer February 19 - 24, 2017
Pathway-Targeted Therapies in Cancer February 23 - 25, 2015
Pathway-Targeted Therapies in Cancer February 9 - 14, 2014
Pathway-Targeted Therapies in Cancer February 23 - 25, 2013
Pathway-Targeted Therapies in Cancer February 19 - 23, 2012